Optivise Advisory Services’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$244K Sell
954
-150
-14% -$36.9K 0.12% 192
2026
Q2
$207K Sell
1,104
-133
-11% -$24.5K 0.1% 216
2026
Q1
$233K Sell
1,237
-230
-16% -$48.5K 0.14% 163
2025
Q4
$292K Sell
1,467
-284
-16% -$57.4K 0.17% 139
2025
Q3
$356K Buy
+1,751
New +$311K 0.21% 109

Other funds holding THC

Optivise Advisory Services's THC Position: Q3 2026 in Review

Optivise Advisory Services reduced its Tenet Healthcare (THC) stake by 14% in Q3 2026, selling an estimated $36.9K and leaving 954 shares worth $244K. The position accounts for 0.12% of the portfolio, ranked #192.

Optivise Advisory Services first reported a position in THC in Q3 2025 and has held it in 5 quarters since. The position peaked at $356K in Q3 2025. 187 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Optivise Advisory Services held 954 shares of Tenet Healthcare worth $244K as of Q3 2026.
  • Optivise Advisory Services sold 150 Tenet Healthcare shares in Q3 2026, an estimated $36.9K.
  • Tenet Healthcare made up 0.12% of Optivise Advisory Services's portfolio in Q3 2026, its #192 holding.
  • Optivise Advisory Services first reported a position in Tenet Healthcare in Q3 2025 and has held it in 5 quarters since.
  • Optivise Advisory Services's Tenet Healthcare position peaked at $356K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Optivise Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.